Simplex Trading
LXRX icon

Simplex Trading’s Lexicon Pharmaceuticals LXRX Stock Holding History

Simplex Trading’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.83K Buy
6,300
+1,700
+37% +$2.47K ﹤0.01% 7377
2025
Q4 		$5.29K Sell
4,600
-32,400
-88% -$44.5K ﹤0.01% 7399
2025
Q3 		$49K Buy
+37,000
New +$42K ﹤0.01% 6480
2025
Q2 		– Sell
-6,200
Closed -$2K – 9285
2025
Q1 		$2K Buy
6,200
+2,800
+82% +$1.77K ﹤0.01% 8014
2024
Q4 		$2K Buy
+3,400
New +$4.1K ﹤0.01% 8031
2024
Q3 		– Sell
-33,100
Closed -$55K – 9108
2024
Q2 		$55K Sell
33,100
-16,700
-34% -$30K ﹤0.01% 5989
2024
Q1 		$119K Buy
49,800
+30,600
+159% +$65.7K ﹤0.01% 5413
2023
Q4 		$29K Buy
+19,200
New +$22.8K ﹤0.01% 6595
2023
Q3 		– Sell
-6,900
Closed -$15K – 9329
2023
Q2 		$15K Sell
6,900
-10,500
-60% -$27.9K ﹤0.01% 7036
2023
Q1 		$42K Buy
17,400
+11,900
+216% +$27.3K ﹤0.01% 6121
2022
Q4 		$10K Sell
5,500
-7,100
-56% -$15.1K ﹤0.01% 7552
2022
Q3 		$30K Buy
12,600
+9,800
+350% +$27.1K ﹤0.01% 7076
2022
Q2 		$5K Sell
2,800
-500
-15% -$954 ﹤0.01% 8840
2022
Q1 		$6K Sell
3,300
-38,900
-92% -$108K ﹤0.01% 9300
2021
Q4 		$166K Buy
42,200
+34,500
+448% +$168K ﹤0.01% 5453
2021
Q3 		$33K Hold
7,700
– – ﹤0.01% 8000
2021
Q2 		$35K Buy
+7,700
New +$37.1K ﹤0.01% 8083
2021
Q1 		– Sell
-724
Closed -$247K – 9484
2020
Q4 		$247K Buy
724
+642
+783% +$1.23K ﹤0.01% 4326
2020
Q3 		$11K Sell
82
-18
-18% -$32 ﹤0.01% 6747
2020
Q2 		$19K Sell
100
-46
-32% -$90 ﹤0.01% 6257
2020
Q1 		$28K Sell
146
-13
-8% -$39 ﹤0.01% 5674
2019
Q4 		$65K Sell
159
-69
-30% -$266 ﹤0.01% 4952
2019
Q3 		$68K Buy
228
+88
+63% +$272 ﹤0.01% 4720
2019
Q2 		$88K Sell
140
-119
-46% -$712 ﹤0.01% 4319
2019
Q1 		$144K Sell
259
-483
-65% -$2.93K ﹤0.01% 3951
2018
Q4 		$492K Sell
742
-180
-20% -$1.46K ﹤0.01% 2252
2018
Q3 		$983K Buy
922
+366
+66% +$4.19K ﹤0.01% 1907
2018
Q2 		$667K Buy
556
+486
+694% +$4.97K ﹤0.01% 2174
2018
Q1 		$11K Buy
70
+60
+600% +$555 ﹤0.01% 3956
2017
Q4 		$1K Sell
10
-594
-98% -$6.17K ﹤0.01% 5560
2017
Q3 		$126K Buy
604
+439
+266% +$6.48K 0.01% 1520
2017
Q2 		$18K Sell
165
-496
-75% -$7.68K ﹤0.01% 3403
2017
Q1 		$77K Buy
661
+377
+133% +$5.59K ﹤0.01% 1976
2016
Q4 		$11K Buy
284
+198
+230% +$3.18K ﹤0.01% 3656
2016
Q3 		$6K Sell
86
-664
-89% -$10.7K ﹤0.01% 4117
2016
Q2 		$11K Buy
750
+740
+7,400% +$10K ﹤0.01% 3515
2016
Q1 		$5K Buy
+10
New +$105 ﹤0.01% 4090
2015
Q4 		– Sell
-364
Closed -$116K – 5798
2015
Q3 		$116K Buy
+364
New +$3.98K 0.01% 1306

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Simplex Trading's LXRX Position: Q1 2026 in Review

Simplex Trading sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2026, closing a stake of 14,758 shares — an estimated $21.5K sold.

Simplex Trading first reported a position in LXRX in Q3 2015 and held it in 33 quarters. The position peaked at $535K in Q4 2020. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Simplex Trading reported no remaining Lexicon Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 14,758 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $21.5K.
  • Simplex Trading first reported a position in Lexicon Pharmaceuticals in Q3 2015 and held it in 33 quarters.
  • Simplex Trading's Lexicon Pharmaceuticals position peaked at $535K in Q4 2020.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.